Finding out that you or someone close to you has breast cancer brings up many intense emotions and worries. When doctors talk about different tests, lab reports, and treatment options, the medical terms can feel overwhelming and confusing. One test you will often hear about is the immunohistochemistry or IHC test. Even though the name sounds complicated, please do not feel scared or stressed. This test is a vital tool that helps your doctor choose the safest and most effective treatment specifically tailored to your cancer type. Let us walk through this test together in a very simple, reassuring way.
Understanding how doctors study your cancer cells can give you a strong sense of control and confidence during your care. When you know what tests like the IHC exam are looking for, talking with your medical team becomes much easier. Let us explore the details step by step so you feel fully informed and prepared.
Key Takeaways
- The IHC test helps doctors see what drives your breast cancer growth.
- It checks for hormone receptors like estrogen and progesterone, plus HER2 proteins.
- Test results guide your medical team in choosing targeted medicines and therapies.
- Reviewing your report closely with your doctor ensures you understand every detail.
BMI Calculator
Know your body mass index (BMI) and weight classification
What Is the IHC Test?
Simply put, immunohistochemistry or the IHC test is a special laboratory examination that looks closely at the exact nature of your cancer cells. Not all breast cancers are alike or grow in the exact same way. Some breast cancers grow by using natural hormones found inside your body. Other types grow and spread by depending on specific proteins.
When your doctor discovers exactly which factors help your cancer grow, they can target those exact elements with medicine. The IHC test primarily looks for two key features within your tissue sample:
- Hormone Receptors: Our bodies naturally produce hormones called estrogen and progesterone. Some breast cancer cells have special spots on their outer surface called receptors where these hormones can attach. Once hormones attach to these receptors, they send signals telling the cancer cells to grow and multiply. If your cancer cells have these receptors, the cancer is called hormone receptor-positive.
- HER2 Proteins: HER2 stands for human epidermal growth factor receptor 2. This is a protein that normally helps healthy cells grow. However, some breast cancer cells make too many of these HER2 proteins. When this happens, it is called HER2-positive, which can make the cancer grow much faster.
The main goal of this test is to find out what "food" your cancer uses to grow so doctors can block it with the right medicine.
How Is the IHC Test Done?
This test requires a small sample of your cancer tissue. Doctors usually collect this tissue during a biopsy or when they perform surgery to remove the abnormal area. Once the sample is collected, it is carefully sent to a specialized laboratory for examination.
Inside the laboratory, skilled technicians perform several precise steps to analyze the tissue:
- Lab professionals place a special liquid chemical over your tissue sample containing laboratory-made proteins called antibodies.
- These antibodies are specifically designed to attach only to estrogen, progesterone, or HER2 receptors, much like a specific key fitting into a matching lock.
- If your cancer cells carry these specific receptors, the laboratory antibodies will attach directly to them.
- Technicians then add another chemical solution that changes the color of the cells where the antibodies have attached.
- A trained medical specialist called a pathologist looks through a microscope to see if the cells changed color and counts how many cells show this change.
This careful laboratory process reveals whether your cancer is HER2-positive, hormone receptor-positive, or negative for these markers.
Medical grade state-of-the-art hearing aids
Advanced hearing aids designed for clear hearing and noise control in the ear.
Check Availability →Understanding Your Test Report
Receiving your IHC test report can feel daunting when you see numbers, percentages, and unfamiliar medical words. The most important step is sitting down with your doctor to talk through everything written on your report. Here is how results are typically reported:
HER2 Results
HER2 lab results are usually reported using a clear numerical score:
| Result Score | What It Means |
|---|---|
| 0 or 1+ | This means your cancer is HER2-negative. There are no HER2 receptors or only very low amounts present on the cancer cells. |
| 2+ | This is a borderline or unclear result. It cannot be determined if the cancer is definitely positive or negative. Your doctor will likely order a follow-up test called a FISH test to check further. |
| 3+ | This means your cancer is HER2-positive, meaning the cancer cells have high levels of HER2 proteins. |
Hormone Receptor (ER and PR) Results
Hormone receptor results can be reported in a few different ways:
- As a Percentage (0% to 100%): This tells you out of 100 cancer cells, how many tested positive for hormone receptors.
- On a Scale of 0 to 3: A score of 0 means no receptors are present, while 1, 2, and 3 show low, moderate, and high receptor levels.
- Allred Score (0 to 8): Higher scores indicate greater receptor presence and clearer test findings.
- Positive or Negative: Positive means receptors are found. Even a low percentage like 1% can sometimes be considered positive, making the exact percentage very helpful to know.
Sometimes lab errors happen. If you ever feel uncertain about your results, never hesitate to ask your doctor to have another pathologist review your slide or repeat the test.
How IHC Results Shape Your Treatment
This is one of the most important parts of your care journey. Your medical oncologist looks closely at your IHC results to build the safest and most effective treatment plan for you.
| Cancer Type by IHC Result | Matching Treatment Options |
|---|---|
| HER2-positive | Targeted therapies that specifically attack the HER2 protein work very well for this type. |
| HER2-negative | This type often grows more slowly, but anti-HER2 medicines do not work here. Your doctor may choose chemotherapy or hormone therapies instead. |
| Hormone receptor-positive (ER+ and/or PR+) | Hormone therapy is extremely effective. These medicines lower estrogen levels or stop estrogen from reaching cancer cells. |
| Hormone receptor-negative | These cancers tend to grow faster, and hormone treatments will not affect them. Other options like chemotherapy are needed. |
| Triple-positive | This means estrogen, progesterone, and HER2 are all positive. Patients can receive both hormone therapies and targeted HER2 treatments. |
| Triple-negative | This means all three markers are negative. Because hormone or targeted medicines do not work here, treatments usually include surgery, chemotherapy, and radiation therapy. |
When to Seek Urgent Medical Help
While waiting for lab results or during treatment, watch for red flag symptoms like sudden severe shortness of breath, chest pain, high fever over 101°F (38.3°C), or severe bleeding. If you experience these urgent symptoms, call 911 (US/Canada), 999 (UK), or go to your nearest emergency department right away.
💡 Take-Home Message
- The IHC test is a crucial step when planning personalized breast cancer care. There is no need to fear the name.
- The test checks whether your cancer depends on hormones or HER2 proteins to grow and multiply.
- Results help your doctor choose the most effective treatment with fewer side effects.
- Always review your report thoroughly with your medical team and ask any questions you have.
- Being an active part of your healthcare decisions gives you confidence and better peace of mind.
No comments yet. Be the first to share your question or experience below.